The origin of Behçet's disease geoepidemiology: Possible role of a dual microbial-driven genetic selection

Clinical and Experimental Rheumatology

Volumn 32, Issue , 2014, Pages S123-S129

  Piga, Matteo ^a   Mathieu, Alessandro ^a  

^a DEPARTMENT OF RADIOLOGY   (Italy)

Author keywords

Beh et's disease; Epidemiology; Genetic selection; HLA B51; Infectious disease; Malaria; MHC region; Plague; TNF alpha

Indexed keywords

HLA B51 ANTIGEN;

BEHCET DISEASE; ENDEMIC DISEASE; EVOLUTIONARY ADAPTATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SELECTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; MALARIA FALCIPARUM; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; REVIEW; YERSINIA PESTIS; BEHCET SYNDROME; EVOLUTION; GENETICS; MALARIA, FALCIPARUM; PLAGUE;

BEHCET SYNDROME; BIOLOGICAL EVOLUTION; HUMANS; MALARIA, FALCIPARUM; PLAGUE; PLASMODIUM FALCIPARUM; SELECTION, GENETIC; YERSINIA PESTIS;

EID: 84907513503     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Le SOUEF PN, GOLDBLATT J, LYNCH NR. Evolutionary adaptation of inflammatory immune responses in human beings. Lancet 2000; 356: 242-4.
2. COOKE GS, HILL AV: Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001; 2: 967-77.
3. SMITH KG, CLATWORTHY MR: Fcgamma RIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 2010; 10: 328-43.
4. BARNES KC, GRANT AV, GAO P. A review of the genetic epidemiology of resistance to parasitic disease and atopic asthma: common variants for common phenotypes? Curr Opin Allergy Clin Immunol 2005; 5: 379-85.
5. TOUMA Z, FARRA C, HAMDAN A et al.: TNF polymorphisms in patients with Behçet disease: a meta-analysis. Arch Med Res 2010; 41: 142-6.
6. REMMERS EF, COSAN F, KIRINO Y et al.: Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 2010;42:698-702.
7. De MENTHON M, LAVALLEY MP, MALDINI C, GUILLEVIN L, MAHR A: HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009; 61: 1287-96.
8. VERITY DH, MARR JE, OHNO S, WALLACE GR, STANFORD MR: Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999; 54: 213-20.
9. OHNO S, OHGUCHI M, HIROSE S, MATSUDA H, WAKISAKA A, AIZAWA M: Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982; 100: 1455-8.
10. PIGA M, MATHIEU A: Genetic susceptibility to Behçet's disease: role of genes belonging to the MHC region. Rheumatology (Oxford). 2011; 50: 299-310.
11. TANABE K, MITA T, JOMBART T et al.: Plasmodium falciparum accompanied the human expansion out of Africa. Curr Biol 2010; 20: 1283-9.
12. HENN BM, CAVALLI-SFORZA LL, FELDMAN MW: The great human expansion. Proc Natl Acad Sci USA 2012; 109: 17758-64.
13. SNOW RW, GUERRA CA, NOOR AM, MYINT HY, HAY SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434: 214-7.
14. JOY DA, FENG X, MU J: Early origin and recent expansion of Plasmodium falciparum. Science 2003; 300: 318-21.
15. CONTU L, CARCASSI C, ORRÙ S et al.: HLA-B35 frequency variations correlate with malaria infection in Sardinia. Tissue Antigens 1998; 52: 452-61.
16. HILL AV, ALLSOPP CE, KWIATKOWSKI D et al.: Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600.
17. KUBO H, IKEDA-MOORE Y, KIKUCHI A et al.: Residue 116 determines the C-terminal anchor residue of HLA-B*3501 and-B*5101 binding peptides but does not explain the general affinity difference. Immunogenetics 1998; 47: 256-63.
18. MATHIEU A, CAULI A, FIORILLO MT, SORRENTINO R: HLA-B27 and ankylosing spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis. Autoimmun Rev 2008; 7: 398-403.
19. GUL A, UYAR FA, INANC M et al.: A weak association of HLA-B*2702 with Behçet's disease. Genes Immun 2002; 3: 368-72.
20. MAGNACCA A, PERSICONI I, NURZIA E et al.: Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules. J Biol Chem 2012; 287: 30358-67.
21. PIGA M, PALADINI F, LAI S et al.: Genetics of Behçet's disease in Sardinia: two distinct extended HLA haplotypes harbour the B*51 allele in the normal population and in patients. Clin Exp Rheumatol 2012; 30 (Suppl. 72): S51-S56.
22. HANANANTACHAI H, PATARAPOTIKUL J, OHASHI J et al.: Significant association between TNF-alpha (TNF) promoter allele (-1031C,-863C, and-857C) and cerebral malaria in Thailand. Tissue Antigens 2007; 69: 277-80.
23. AHMAD T, WALLACE GR, JAMES T et al.: Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 2003; 48: 807-13.
24. KATO N, WARD F, KANO K, TAKIGUCHI M: Conservation of genes encoding HLA-B5 and B35 cross-reactive group antigens in various races. Hum Immunol 1992;35: 253-5.
25. ABI-RACHED L, JOBIN MJ, KULKARNI S et al.: The shaping of modern human immune systems by multiregional admixture with archaic humans. Science 2011; 334: 89-94.
26. GREEN RE, KRAUSE J, BRIGGS AW et al.: A draft sequence of the Neandertal genome. Science. 2010;328:710-22.
27. BAENA A, LEUNG JY, SULLIVAN AD et al.: TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun 2002; 3: 482-7.
28. TAKEMOTO Y, NARUSE T, NAMBA K et al.: Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's disease. Tissue Antigens 2008; 72: 347-53.
29. ACHTMAN M, ZURTH K, MORELLI G, TORREA G, GUIYOULE A, CARNIEL E: Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 1999; 96: 14043-8.
30. MORELLI G, SONG Y, MAZZONI CJ et al.: Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet 2010; 42: 1140-3.
31. COHN SK Jr., WEAVER LT: The Black Death and AIDS: CCR5-Delta32 in genetics and history. QJM 2006; 99: 497-503.
32. HAENSCH S, BIANUCCI R, SIGNOLI M et al.: Distinct clones of Yersinia pestis caused the black death. PLoS Pathog 2010; 6: e1001134.
33. SMILEY ST: Immune defense against pneumonic plague. Immunol Rev 2008; 225: 256-71.
34. PARENT MA, WILHELM LB, KUMMER LW, SZABA FM, MULLARKY IK, SMILEY ST: Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection. Infect Immun 2006; 74: 3381-6.
35. LUKASZEWSKI RA, KENNY DJ, TAYLOR R, REES DG, HARTLEY MG, OYSTON PC: Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils. Infect Immun 2005; 73: 7142-50.
36. SAIKH KU, KISSNER TL, DYAS B, TROPEA JE, WAUGH DS, ULRICH RG: Human cytolytic T cell recognition of Yersinia pestis virulence proteins that target innate immune responses. J Infect Dis 2006; 194: 1753-60.
37. PINETON DE CHAMBRUN M, WECHSLER B, GERI G, CACOUB P, SAADOUN D: New insights into the pathogenesis of Behçet's disease. Autoimmun Rev 2012; 11: 687-98.
38. HATEMI G, SEYAHI E, FRESKO I, HAMURYUDAN: Behçet's syndrome: a critical digest of the recent literature. Clin Exp Rheumatol 2012; 30 (Suppl. 72): S80-S9.
39. SOHN S, LEE ES, BANG D: Learning from HSV-infected mice as a model of Behçet's disease. Clin Exp Rheumatol 2012; 30 (Suppl.72): S96-S103.
40. GUL A, HAJEER AH, WORTHINGTON J, BARRETT JH, OLLIER WE, SILMAN AJ: Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 2001; 44: 239-40.
41. HUGHES T, COIT P, ADLER A et al.: Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet 2013; 45: 319-24.
42. MIZUKI N, MEGURO A, OTA M et al.: Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 2010;42:703-6.
43. KIRINO Y, BERTSIAS G, ISHIGATSUBO Y et al.: Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 2013; 45: 202-7.
44. ZHANG YJ, XU WD, DUAN ZH, LIU SS, PAN HF, YE DQ: Lack of association between CTLA-4 +49A/G and-318C/T polymorphisms and Behçet's disease risk: a meta-analysis. Clin Exp Rheumatol 2012; 30 (Suppl. 72): S46-50.
45. GUL A, HAJEER AH, WORTHINGTON J, OLLIER WE, SILMAN AJ: Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23. Arthritis Rheum 2001; 44: 2693-6.
46. KARASNEH J, GUL A, OLLIER WE, SILMAN AJ, WORTHINGTON J: Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum 2005; 52: 1836-42.
47. GUL A, INANC M, OCAL L, ARAL O, KONICE M: Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis 2000; 59: 622-5.
48. MANOLIO TA, COLLINS FS, COX NJ et al.: Finding the missing heritability of complex diseases. Nature 2009; 461: 747-53.
49. GUINAN KJ, CUNNINGHAM RT, MEENAGH A, DRING MM, MIDDLETON D, GARDINER CM: Receptor systems controlling natural killer cell function are genetically stratified in Europe. Genes Immun 2010; 11: 67-78.
50. TURNER JK, XU JL, TAPPING RI: Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice. Infect Immun 2009; 77: 367-73.
51. NIIKURA M, KAMIYA S, NAKANE A, KITA K, KOBAYASHI F: IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites. Int J Parasitol 2010; 40: 101-8.
52. LIOZON E, ROUSSIN C, PUéCHAL X et al.: Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros). Joint Bone Spine 2011; 78: 166-70.
53. YAZICI H, UGURLU S, SEYAHI E: Behçet syndrome: is it one condition? Clin Rev Allergy Immunol 2012; 43: 275-80.
54. VIJAYA LAKSHMI V, RAKH SS, ANU RADHA B et al.: Role of HLA-B51 and HLA-B52 in susceptibility to pulmonary tuberculosis. Infect Genet Evol 2006; 6: 436-39.
55. ZHANG Y, PENG Y, YAN H et al.: Multilayered defense in HLA-B51-associated HIV viral control. J Immunol 2011; 187: 684-91.
56. SINGH R, KAUL R, KAUL A, KHAN K: A comparativereview of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007; 13: 1770-87.
57. VAN EPPS HL, SCHMALJOHN CS, ENNIS FA: Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J Virol 1999; 73: 5301-08.